Methoxamine
- Level
- Commodity
- Parent
- 51391700
- Below
- 0
- Links · KBLI
- 8
Definition
UNSPSC 51391727This classification denotes an alpha-adrenergic agonist with the molecular formula C11H17NO3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier HUQ1KC1YLI, chemically known as 2-amino-1-(2,5-dimethoxyphenyl)propanol but generally known as methoxamine, which bears US NIH Compound Identifier 6082. European Medicines Agency schedules Methoxamine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB08857MIG. The term METHOXAMINE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 38, No. 6, 1984, List 24). World Health Organization schedules methoxamine in its Anatomical Therapeutic Chemical (ATC) Classification. METHOXAMINE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule methoxamine under HS 29225000 and SITC 51467. As of Q4 2014, METHOXAMINE remains the US FDA Preferred Term for this commodity. Methoxamine bears US NLM identifiers UMLS ID C0025681 and NCI Concept Code C66119. SMILES: CC(C(C1=C(C=CC(=C1)OC)OC)O)N.
Same parent
Under 51391700 · 48Activities that produce or sell this
KBLI · 8Inherited from family 51390000.
Warning
The links were generated with a large language model (Gemini 3.5 Flash), matching UNSPSC at the family level to KBLI at the kelompok level. Some of them maybe are wrong, so check any link you intend to rely on.